💨 Abstract

On May 9, 2025, SpringWorks Therapeutics Inc. (SWTX) reported a first-quarter loss of $83.2 million, or $1.11 per share, missing Wall Street expectations of an 81 cents per share loss. The company's revenue of $49.1 million also fell short of analysts' forecasts of $64.2 million.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖

Powered by MessengerX.io